drugset / Trial / NCT02012608
Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is a single-centered, double-blind, two-arm randomized study to determine if oral glutamine will reduce radiation toxicity for the subjects undergoing Breast Conserving Therapy.
Timeline
- Start
- 2014-06
- Primary completion
- 2019-04
- Completion
- 2019-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Glutamine | Other / unclassified | 10 g | Oral |